Stay updated on Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now presents the NCT02641093 study record, including eligibility criteria, study locations, treatment plan, outcome measures, and record dates. It also includes a study protocol and statistical analysis plan document.
    Difference
    49%
    Check dated 2026-11-11T01:37:33.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:52:27.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces website updates and a terminology transition, while the study-record area continues to show a 403 Forbidden error. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:53:59.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:28:26.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the study record with an error page. This prevents users from viewing the study's details, locations, and contact information.
    Difference
    18%
    Check dated 2026-09-23T00:20:54.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page revision was updated to v3.7.0. This indicates a deployment/version update to the page template and underlying systems rather than any new or altered study information visible to users.
    Difference
    0.1%
    Check dated 2026-09-16T00:07:26.000Z thumbnail image

Stay in the know with updates to Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page.